Trial intelligence / Profile preview

Clonazepam and Paroxetine in Panic Disorder

NCT02852577Phase 4Completed

Sponsor
Federal University of Rio de Janeiro
Start
Jan 2000
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in panic disorder comparing Clonazepam with Paroxetine (2 arms). Primary endpoint: Clinical Global Impression - Severity at 8 weeks. Started Jan 2000; status: completed.

02

Drugs

clonazepamparoxetine
03

Conditions

panic disorder

Beyond the preview

Go deeper on NCT02852577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02852577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call